Immunosurveillance of childhood ALL: Polymorphic interferon-γ alleles are associated with age at diagnosis and clinical risk groups

Leukemia

Volumn 19, Issue 1, 2005, Pages 44-48

  Cloppenborg, T ^a   Stanulla, M ^a   Zimmermann, M ^a   Schrappe, M ^a   Welte, K ^a   Klein, Christop ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute lymphoblastic leukemia; Genotype; Interferon gamma; Tumor immunity

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL LINEAGE; CHILD; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; IMMUNOSURVEILLANCE; INCIDENCE; INFANT; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RISK FACTOR; TUMOR IMMUNITY;

EID: 11844304952     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403553     Document Type: Article

References (24)

1. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3: 991-998.
2. Street SE, Cretney E, Smyth MJ. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 2001; 97: 192-197.
3. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410: 1107-1111.
4. Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1994; 1: 447-456.
5. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998; 95: 7556-7561.
6. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
7. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863-866.
8. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K. Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 1998; 8: 1013-1017.
9. Jahromi M, Millward A, Demaine A. A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res 2000; 20: 187-190.
10. Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20: 885-888.
11. Pokorny V, McLean L, McQueen F, Abu-Maree M, Yeoman S. Interferon-gamma microsatellite and rheumatoid arthritis. Lancet 2001; 358: 122-123.
12. Lee JY, Goldman D, Piliero LM, Petri M, Sullivan KE. Interferon-gamma polymorphisms in systemic lupus erythematosus. Genes Immun 2001; 2: 254-257.
13. Asderakis A, Sankaran D, Dyer P, Johnson RW, Pravica V, Sinnott PJ et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674-677.
14. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594-1600.
15. Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, Sinnott PJ et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 1999; 60: 343-346.
16. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003; 361: 1871-1872.
17. Reynard MP, Turner D, Junqueira-Kipnis AP, Ramos de Souza M, Moreno C, Navarrete CV. Allele frequencies for an interferon-gamma microsatellite in a population of Brazilian leprosy patients. Eur J Immunogenet 2003; 30: 149-151.
18. Mekus F, Dork T, Deufel T, Morral N, Tummler B. Analysis of microsatellites by direct blotting electrophoresis and chemiluminescence detection. Electrophoresis 1995; 16: 1886-1888.
19. Nieters A, Brems S, Becker N. Cross-sectional study on cytokine polymorphisms, cytokine production after T-cell stimulation and clinical parameters in a random sample of a German population. Hum Genet 2001; 108: 241-248.
20. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639-649.
21. Salkowski CA, Vogel SN. IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. J Immunol 1992; 148: 2770-2777.
22. Schmiegelow K, Garred P, Lausen B, Andreassen B, Petersen BL, Madsen HO. Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood 2002; 100: 3757-3760.
23. Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 2002; 16 1437-1442.
24. Dabora SL, Roberts P, Nieto A, Perez R, Jozwiak S, Franz D et al. Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet 2002; 71: 750-758.